Company

CuraMedix Logo

CuraMedix is the leading U.S. distributor of STORZ Medical Extracorporeal Pulse Activation Technology (EPAT) devices and an emerging leader in the medical technology field focused on regenerative medicine and non-invasive healing solutions, that include the treatment of acute and chronic musculoskeletal pain as well as connective tissue disorders.

EPAT® is a proprietary form of Extracorporeal Shock Wave Technology (ESWT) that utilizes high energy acoustic pressure waves.

Today, extracorporeally generated shock waves and pressure waves are used in a wide variety of medical disciplines.  This non-invasive procedure dates back to the 1960s when the idea emerged to generate shock waves extracorporeally and then transmit them into the body to disintegrate kidney stones and gallstones without damage to surrounding tissue passed by the acoustic waves on their way to the target area.

The CuraMedix EPAT device portfolio includes a variety of consoles, specialized handpieces, and patented applicators that deliver non-surgical treatment solutions to a broad range of medical specialties to include: orthopedics, sports medicine, pain management, rehabilitation, regenerative medicine, urology, aesthetic medicine wound care, and veterinary medicine.

Based in Lincoln, Rhode Island, CuraMedix is committed to providing each one of its partners exceptional customer service, marketing guidance, and technical support and has been a trusted partner of STORZ Medical for over 10 years.

Storz Medical

Established in 1987, STORZ Medical is a Swiss member company of the KARL STORZ Group. From the company’s headquarters in Tägerwilen, STORZ Medical develops innovative shock wave systems that meet the highest standards of precision. Medical specialists and patients all over the world know they can rely on the experience and expertise of STORZ Medical.